Alfonso Valencia

Rare Diseases, Biobanks, Clinical BioinformaticsDespite examples of excellent practice, rare disease (RD) research is still mainly fragmented by data and disease types. Individual efforts have little interoperability and almost no systematic connection between detailed clinical and genetic information, biomaterial availability or research/trial datasets. By developing robust...

El objetivo general del proyecto es promover la colaboración en I+d+i, estimular el aprendizaje mutuo y fomentar la innovación en la atención integrada del ictus, gracias a la incorporación de nuevas tecnologías de análisis de datos y la creación de una red permanente que brinde a todos los stakeholders involucrados en las...

In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium was formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease. BLUEPRINT focused on distinct types of haematopoietic cells from...